OBJECTIVES: Contemporary data are lacking with respect to the incidence rates of, factors associated with, and impact of cardiac arrest from ventricular fibrillation or tachycardia (VF-CA) on hospital survival in patients admitted with an acute coronary syndrome (ACS). The objectives of this multinational study were to characterize trends in the magnitude of in-hospital VF-CA complicating an ACS and to describe its impact over time on hospital prognosis. METHODS: In 59 161 patients enrolled in the Global Registry of Acute Coronary Events Study between 2000 and 2007, we determined the incidence, prognosis, and factors associated with VF-CA. RESULTS: Overall, 3618 patients (6.2%) developed VF-CA during their hospitalization for an ACS. Incidence rates of VF-CA declined over time. Patients who experienced VF-CA were on average older and had a greater burden of cardiovascular disease, yet were less likely to receive evidence-based cardiac therapies than patients in whom VF-CA did not occur. Hospital death rates were 55.3% and 1.5% in patients with and without VF-CA, respectively. There was a greater than 50% decline in the hospital death rates associated with VF-CA during the years under study. Patients with a VF-CA occurring after 48 h were at especially high risk for dying during hospitalization (82.8%). CONCLUSION: Despite reductions in the magnitude of, and short-term mortality from, VF-CA, VF-CA continues to exert an adverse effect on survival among patients hospitalized with an ACS. Opportunities exist to improve the identification and treatment of ACS patients at risk for VF-CA to reduce the incidence of, and mortality from, this serious arrhythmic disturbance.
OBJECTIVES: Contemporary data are lacking with respect to the incidence rates of, factors associated with, and impact of cardiac arrest from ventricular fibrillation or tachycardia (VF-CA) on hospital survival in patients admitted with an acute coronary syndrome (ACS). The objectives of this multinational study were to characterize trends in the magnitude of in-hospital VF-CA complicating an ACS and to describe its impact over time on hospital prognosis. METHODS: In 59 161 patients enrolled in the Global Registry of Acute Coronary Events Study between 2000 and 2007, we determined the incidence, prognosis, and factors associated with VF-CA. RESULTS: Overall, 3618 patients (6.2%) developed VF-CA during their hospitalization for an ACS. Incidence rates of VF-CA declined over time. Patients who experienced VF-CA were on average older and had a greater burden of cardiovascular disease, yet were less likely to receive evidence-based cardiac therapies than patients in whom VF-CA did not occur. Hospital death rates were 55.3% and 1.5% in patients with and without VF-CA, respectively. There was a greater than 50% decline in the hospital death rates associated with VF-CA during the years under study. Patients with a VF-CA occurring after 48 h were at especially high risk for dying during hospitalization (82.8%). CONCLUSION: Despite reductions in the magnitude of, and short-term mortality from, VF-CA, VF-CA continues to exert an adverse effect on survival among patients hospitalized with an ACS. Opportunities exist to improve the identification and treatment of ACS patients at risk for VF-CA to reduce the incidence of, and mortality from, this serious arrhythmic disturbance.
Authors: Kim A Eagle; Brahmajee K Nallamothu; Rajendra H Mehta; Christopher B Granger; Philippe Gabriel Steg; Frans Van de Werf; Jose López-Sendón; Shaun G Goodman; Ann Quill; Keith A A Fox Journal: Eur Heart J Date: 2008-03 Impact factor: 29.983
Authors: Harold L Dauerman; Darleen Lessard; Jorge Yarzebski; Joel M Gore; Robert J Goldberg Journal: Am J Cardiol Date: 2005-09-27 Impact factor: 2.778
Authors: Keith A A Fox; Philippe Gabriel Steg; Kim A Eagle; Shaun G Goodman; Frederick A Anderson; Christopher B Granger; Marcus D Flather; Andrzej Budaj; Ann Quill; Joel M Gore Journal: JAMA Date: 2007-05-02 Impact factor: 56.272
Authors: Robert J Goldberg; Jorge Yarzebski; Frederick A Spencer; Juan C Zevallos; Darleen Lessard; Joel M Gore Journal: Am J Cardiol Date: 2008-09-27 Impact factor: 2.778
Authors: Karen S Pieper; Joel M Gore; Gordon FitzGerald; Christopher B Granger; Robert J Goldberg; Gabriel Steg; Kim A Eagle; Frederick A Anderson; Andrzej Budaj; Keith A A Fox Journal: Am Heart J Date: 2009-06 Impact factor: 4.749